These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19734644)

  • 1. Bisphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy.
    Erkan M; Bilgi O; Mutluoğlu M; Uzun G
    JOP; 2009 Sep; 10(5):579-80; author reply 581-2. PubMed ID: 19734644
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates.
    Ryan P; Saleh I; Stassen LF
    Postgrad Med J; 2009 Dec; 85(1010):674-7. PubMed ID: 20075406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.
    Freiberger JJ; Padilla-Burgos R; Chhoeu AH; Kraft KH; Boneta O; Moon RE; Piantadosi CA
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1321-7. PubMed ID: 17577496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws.
    Freiberger JJ
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):96-106. PubMed ID: 19371820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.
    Ruggiero SL; Mehrotra B
    Annu Rev Med; 2009; 60():85-96. PubMed ID: 18928335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonate related osteonecrosis of the jaws: a review and update.
    Weeda L
    J Tenn Dent Assoc; 2009; 89(2):16-9; quiz 20-1. PubMed ID: 19630246
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions.
    Woo SB; Solomon DH
    J Natl Cancer Inst; 2007 Jul; 99(13):986-7. PubMed ID: 17596571
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
    Diel IJ; Fogelman I; Al-Nawas B; Hoffmeister B; Migliorati C; Gligorov J; Väänänen K; Pylkkänen L; Pecherstorfer M; Aapro MS
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):198-207. PubMed ID: 17855108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw & osteoporosis therapy.
    Kessenich CR
    Nurse Pract; 2010 Jul; 35(7):51-3. PubMed ID: 20555246
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
    Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
    Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate related osteonecrosis of the jaws.
    Fung E
    J Rheumatol; 2009 Feb; 36(2):450; author reply 453. PubMed ID: 19208578
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
    Bagán J; Blade J; Cozar JM; Constela M; García Sanz R; Gómez Veiga F; Lahuerta JJ; Lluch A; Massuti B; Morote J; San Miguel JF; Solsona E
    Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E336-40. PubMed ID: 17664922
    [No Abstract]   [Full Text] [Related]  

  • 15. Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw.
    Setabutr D; Hales NW; Krempl GA
    Am J Otolaryngol; 2010; 31(2):127-9. PubMed ID: 20015718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of complications of bisphosphonates in oncology patients: jaw osteonecrosis].
    Madrid C; Jaques B; Bouferrache K; Broome M
    Rev Med Suisse; 2007 May; 3(112):1322, 1324-6, 1329-31. PubMed ID: 17596069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-associated osteonecrosis of the jaw: questioning the proposed protocols.
    Leon SP
    Dent Today; 2006 Nov; 25(11):16; author reply 16. PubMed ID: 17128703
    [No Abstract]   [Full Text] [Related]  

  • 20. Consider informed consent policy for treating bisphosphonate patients.
    Bittinger A
    Todays FDA; 2007 Jan; 19(1):9-10. PubMed ID: 17668502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.